Elevance Health, Inc. (NYSE: ELV) saw mixed analyst activity and mounting legal pressures today. Investors cheered continued buy ratings and lofty price targets from Bernstein and Wells Fargo, while Barclays trimmed its target. Offsetting those positives, a Zacks preview warns of weaker Q2 earnings, the stock hit a 52-week low, and multiple law firms have filed or solicited investors for securities-fraud class actions.
Positive Sentiment:
Bernstein reaffirms its Buy rating on ELV, signaling confidence in the company’s long-term growth prospects.
Bernstein Sticks to Its Buy Rating for Elevance Health (ELV)
Positive Sentiment:
Wells Fargo maintains a Buy on ELV and sets a $478 price target, reinforcing bullish analyst outlook.
Wells Fargo Maintains a Buy on Elevance Health (ELV), Sets a $478 PT
Positive Sentiment:
Bernstein also upholds its Buy rating with an even higher $585 target, suggesting further upside.
Bernstein Maintains a Buy on Elevance Health (ELV), Sets a $585 PT
Neutral Sentiment:
Barclays cuts its price target from $480 to $434 but keeps an Overweight rating, indicating cautious optimism despite valuation concerns.
Elevance Health (NYSE:ELV) Price Target Cut to $434.00 by Analysts at Barclays
Negative Sentiment:
Zacks warns Q2 earnings are expected to decline, lacking the drivers needed for an upside surprise.
Earnings Preview: Elevance Health (ELV) Q2 Earnings Expected to Decline
Negative Sentiment:
ELV hits a new 52-week low, reflecting short-term selling pressure.
Elevance Health (NYSE:ELV) Reaches New 52-Week Low - Here's What Happened
Negative Sentiment:
Glancy Prongay & Murray LLP announces an opportunity for ELV investors to lead a securities-fraud class action.
Elevance Health, Inc. (ELV) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Negative Sentiment:
Berger Montague PC urges investors to contact the firm by July 11 to seek lead-plaintiff status in a class action.
DEADLINE TOMORROW: Berger Montague Advises Elevance Health (NYSE: ELV) Investors to Contact the Firm Before July 11, 2025
Negative Sentiment:
Bleichmar Fonti & Auld LLP files suit alleging fraud; investors told to act by July 11.
ELV COURT NOTICE: Investors may have been Affected by Fraud — Contact BFA Law by the July 11 Deadline
Negative Sentiment:
Pomerantz LLP reminds ELV shareholders of class action deadlines after reporting losses.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors of Class Action Lawsuit
Negative Sentiment:
Bronstein, Gewirtz & Grossman LLC notifies investors of an opportunity to lead a securities-fraud suit.
ELV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces Opportunity to Lead Class Action
Posted 6h ago
AI Generated. May Contain Errors.